Blogg

Health Policy Outlook for 2022

Members of the Washington, D.C. government affairs firm Thorn Run Partners came to the March Policy Advisory Council meeting to discuss what is on the horizon for health policy in 2022.

Bone Health Roundtable: Importance of Women’s Bone Health Throughout the Lifespan

SWHR convened an interdisciplinary Bone Health Working Group of health care providers, researchers, patient advocates, and policy leaders for a closed, roundtable meeting in April 2022. During the roundtable, the Working Group discussed scientific and policy issues in women’s bone health, including strategies for fracture prevention in at-risk women.

Congress Unveils Fiscal Year 2022 Omnibus Text

The text of the Consolidated Appropriations Act, 2022 (H.R. 2471) includes emergency funding for COVID-19 and Ukraine, and other provisions.

SWHR Responds to OSTP Request for Information on Strengthening Community Health Through Technology

SWHR Statement on Dr. Robert Califf Appointment

SWHR released a statement following the Senate’s confirmation of Dr. Robert Califf to serve as the Commissioner of Food and Drugs, Food and Drug Administration.

Narcolepsy Program Roundtable: The Impact of Narcolepsy on Women’s Health Across the Lifespan

SWHR convened an interdisciplinary working group to discuss scientific and policy issues around narcolepsy in women, including strategies for better symptom management and how to improve access to treatments and care.

SWHR Comments to NIH on Draft COSWD Strategic Plan (FYs 22-26)

SWHR Provides Comments to CMS on Medicare Coverage Policy for Monoclonal Antibodies Directed Against Amyloid for the Treatment of AD

SWHR Submits Feedback on Draft Protocol of IVI’s Economic Model for MDD

SWHR Statement on Bipartisan Effort to Address the Needs of Pregnant and Lactating Women

SWHR released a statement in response to a January 2022 bipartisan congressional letter to HHS Secretary Becerra on pregnant and lactating women.